Notice ID: 93af703349d24ab4b39a9ea08f6a7311Special Notice
Notice of Intent to Sole Source - Aptamer Library Generation Services for USAMRIID
Archived on March 6, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM UTC−05:00
- Posted
- January 23, 2025
- Notice type
- Special Notice
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- ARMY MED RES ACQ ACTIVITY
- Place of performance
- MD, 21702
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- HT942525R0028
- Notice ID
- 93af703349d24ab4b39a9ea08f6a7311
Description
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a Firm Fixed Price, sole source, contract on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Aptagen, LLC located at 250 N Main Street, Jacobus, PA 17407, under the authority as prescribed in FAR 13.501 (a) (1) ( ii), sole source (including brand name) under the authority of simplified procedures for certain commercial items. This new requirement is for the need to generate two (2) Deoxyribonucleic Acid (DNA) Aptamer Library Generation per anticipated projects per year. These aptamer libraries will consist of ~1000 - ~10,000 targeted aptamers. These libraries will target specific alpha-conotoxins and palytoxins and should be capable of broad-spectrum interactions and libraries targeting four (4) to six (6) viral targets. This new requirement was identified to support USAMRIIDs project NB38075, Development of broad-spectrum DNA aptamers to neutralize toxins. Aptagen LLC is the only vendor capable of providing reagents that can be used on site to initiate the process, train in their use, and then synthesize and characterize the aptamers that are promising candidates. Aptagen, LLC is a leader in aptamer library generation. Aptagen owns its proprietary processes of aptamer development. They are the only company to provide aptamer library kits along with library characterization services. Further, Aptagen LLC provides the ability for USAMRIID to leverage its expertise while retaining possession of the select agent in accordance with USAMRIIDs strict and rigorous access and control protocols, allowing for the production of the libraries within said containment parameters. This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these services. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement. Capability statements are due no later than 1300 Eastern Time, 06 February 2025. Capability statements shall be submitted, via email ONLY, as a Microsoft Word or Adobe PDF attachment to the following email addresses christina.m.lewis14.civ@health.mil and jayme.l.fletcher2.civ@health.mil. No phone calls will be accepted.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
HT942525R0028- Special NoticeCurrentJan 23, 2025
Notice of Intent to Sole Source - Aptamer Library Generation Services for USAMRIID
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Redacted J&A posted in accordance with RFO 6.301 | - | Sole Source / J&A | Open |
See Soliciation Amendments 0001, 0002, and 0003. USAISR's Combat Casualty Care Research Team 1 (CRT-1) requires resupply of its Blood Donor Room on a reoccurring basis in order to satisfy research requirements for blood collection. USAISR currently has three Terumo Trima Accel Blood Collection Systems in operation. These units support numerous research protocols. Various collection sets are used to collect a variety of blood products from donors. The Trima instrument is FDA-approved, but only with the use of original manufacturer-supplied consumable products. These consumables are specific to the instrument and there are no generic substitute products available in the marketplace. Please note - This is a 100% set-aside for Service-Disabled Veteran-Owned Small Businesses. See attached complete solicitation for all requirement details and instructions to offerors. | - | Solicitation | 11/20/2026 |
The attached document is the Redacted Justification and Approval for the Other than Full anbd Open Competition of theSequencing System for HIV-1 Testing for WRAIR. | - | Sole Source / J&A | Open |
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers. | - | Combined Synopsis | 11/18/2026 |
DESCRIPTION This RFI is solely for information and planning purposes and does not constitute a solicitation or obligation on the part of the Government. Per FAR 15.201(e), responses to this notice are not considered offers, shall not be used as a proposal, and cannot be accepted by the Government to form a binding contract. Neither unsolicited proposals nor any other kinds of offers will be considered in response to this notice. No evaluation letters and/or results will be issued to the respondents; however, the Government does reserve the right to contact any respondent and/or respondent reference to obtain additional information. At this time, no solicitation exists; therefore, please do not request a copy of the solicitation. Any resulting procurement action will be the subject of a separate, future announcement. The information is provided for discussion purposes and any potential strategy for this acquisition may change prior to any solicitation release. The acquisition strategy, evaluation methodology, contract type, and any other acquisition decisions are to be determined. Background. The offeror shall provide to the Veterans Affairs Medical Health Care System at Baltimore VAMC all reagents and supplies for flow cytometry testing in the Hematology section of Pathology and Laboratory Medicine Service. The reagents/supplies will be used for CD4/CD8 count testing and the phenotyping of white blood cells in the leukemia and lymphoma assay using the Becton Dickinson FACSLyric. QC material and calibration material are used for the detection of voltages and spectral overlap to monitor optimal cytometer settings, checks, and track the daily performance. Performance Period: 12/03/2026 to 12/02/2027 Quantities are estimates: Item # Description Qty 643774 Anti-Kappa FITC TB28-2 ASR 4 642924 Anti-Lambda PE 1-55-2 ASR 4 341103 CD19 PE-Cy7 SJ25C1 ASR 4 340922 CD10 APC HI10a ASR 4 641405 CD20 APC-H7 L27 ASR 4 646852 CD38 V450 ASR 3 647450 CD45 V500-C ASR 4 663985 CD5 (L17F12) BV605 ASR 4 340918 FMC7 FITC ASR 4 340997 CD103 PE Ber-ACT8 ASR 2 659116 CD23 APC-R700 (EBVCS-5) ASR 3 655112 CD11c V450 ASR 3 340706 CD57 FITC HNK-1 ASR 3 340948 CD3 PerCP-Cy5.5 SK7 ASR 3 335804 CD2 PE-Cy7 L303.1 ASR 3 562660 Hu CD25 BV605 2A3 100Tst 3 659115 CD7 APC-R700 (M-T701) ASR 3 641409 CD8 APC-H7 SK1 ASR 3 651850 CD4 V450 (SK3) ASR 3 340688 Anti-HLA-DR FITC L243 (G46-6) ASR 3 644386 CD64 PE 10.1 ASR 3 338432 CD13 PE-Cy7 L138 ASR 3 340667 CD34 APC 8G12 ASR 3 659113 CD33 APC-R700 (P67-6) ASR 3 643077 CD14 APC-H7 MphiP9 ASR 3 663803 CD117 (104D2) BV605 ASR 3 657887 CD56 APC-R700 NCAM16.2 ASR 3 563826 Hu Alp Bta TCR APC T10B9.1A-31 100Tst 2 341635 CD30 PE Ber-H83 ASR 2 341097 CD138 PerCP-Cy5.5 MI15 ASR 2 655019 CD27 APC (L128) ASR 2 665134 CD81 (JS-81) BV605 ASR 2 656311 CD22 PerCP-Cy5.5 (S-HCL-1) ASR 3 663994 CD123 (9F5) APC-R700 ASR 2 649455 CD26 PE (L272) ASR 2 655434 TCR gamma/delta-1 PE-Cy7 (11F2) ASR 2 340655 Anti-MPO FITC 5B8 ASR 2 347209 Anti-TdT PE E17-1519 ASR 2 659114 CD34 APC-R700 (8G12) ASR 3 664538 CD22 (S-HCL-1) PE-Cy7 ASR 2 340653 CD79a APC HM47 ASR 2 341641 CD1a PE SK9 ASR 2 663196 CD158a (HP-3E4) PE ASR 2 663990 CD56 (NCAM16.2) BV605 ASR 2 644490 CD 16 V450 3G8 ASR 2 562361 Hu CD94 PerCP-CY5.5 HP-3D9 100Tst 2 562124 Hu CD200 PerCP-Cy5.5 MRC OX-104 50Tst 3 656152 CD36 FITC CLB-IVC7 ASR 2 562371 Hu CD 15 PE W6D3 100Tst 2 340936 CD11b APC D12 ASR 2 347213 CD34 PerCP-Cy5.5 8G12 ASR 2 340715 CD61 FITC RUU-PL7F12 ASR 2 340946 Glycophorin A PE GAR-2(HIR2) ASR 2 644490 CD 16 V450 3G8 ASR 2 662414 CST beads 150T IVD 2 342003 BD FACSFlow Sheath Fluid 20L 20 349202 BD FACS Lysing Solution 10X 100ML IVD 2 559925 7-AAD Staining Solution 2mL 3 563794 Brilliant Stain Buffer 5ml 6 554656 Stain Buffer FBS 500mL 20 552843 Ms Ig Kpa Comp Bead Set 6mL 1 555899 Lysing Buffer 10X Concentrate 100mL 8 340345 BD FACS Clean Solution 5L 1 562776 Ms CD140A PE APA5 50ug 3 340499 Multitest CD3/CD8/CD45/CD4 50 Tests IVD 30 662961 BD FC Beads 7-Color Kit (US-IVD) 1 349705 Multi-Check CD4 Low Ctrl 5X2.5mL US-IVD 6 349702 Multi-Check Control 5X2.5mL US-IVD 6 661624 BD FC Beads V500-C 1 661623 BD FC Beads V450 1 661626 BD FC Beads BV605 1 661621 BD FC Beads APC-H7 1 661625 BD FC Beads APC-R700 1 RESPONSES: Please include descriptive literature demonstrating the product meets or exceeds the brand name product specified above. Please provide any product solution or configuration so long as they are equivalent to the brand name product. Responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. PLEASE PROVIDE THE FOLLOWING ADDITIONAL INFORMATION: Full name and address of company DUNS number/ CAGE Code/ SAM UEI Business Size Manufacturer or Distributor If distributor, provide full name, business size, and address of manufacturer. Country of Origin designation for all products. Technical Literature that clearly shows product(s) are equivalent. Any additional product solution or configuration that would be beneficial to the functionality of the product line identified. Authorized Distributor Letter Certified by OEM with a current date. Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement. | - | Market Research | 11/12/2026 |
Additional Details
Solicitation Number
HT942525R0028
Archive Date
Mar 6, 2025
Office Address
FORT DETRICK, MD, 21702